JP2685055B2 - Oral mucosa patch containing Sikon - Google Patents
Oral mucosa patch containing SikonInfo
- Publication number
- JP2685055B2 JP2685055B2 JP63057052A JP5705288A JP2685055B2 JP 2685055 B2 JP2685055 B2 JP 2685055B2 JP 63057052 A JP63057052 A JP 63057052A JP 5705288 A JP5705288 A JP 5705288A JP 2685055 B2 JP2685055 B2 JP 2685055B2
- Authority
- JP
- Japan
- Prior art keywords
- cellulose
- water
- adhesive layer
- patch
- oral mucosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Description
【発明の詳細な説明】 産業上の利用分野 本発明はシコン含有口腔粘膜貼付剤、更に詳しくは、
シコン含有粘着層および口腔粘膜に対して非粘着性の支
持体層から成り、口腔内の患部に貼付して抗炎症作用を
長時間にわたつて発揮しうる口腔内製剤に関する。TECHNICAL FIELD OF THE INVENTION The present invention relates to an oral mucosa patch containing silicon, more specifically,
The present invention relates to an intraoral preparation which is composed of a sticky layer containing silicon and a support layer that is non-adhesive to oral mucosa and can be applied to an affected part of the oral cavity to exert an anti-inflammatory effect over a long period of time.
従来技術と発明の解決すべき課題 シコン(紫根)は古来より漢方薬として知られてお
り、たとえばムラサキ科植物の乾燥した根のエキスから
軟膏の「紫雲膏」が作られ、皮膚病、外傷などの妙薬と
して多用されている。Background Art and Problems to be Solved by the Invention Sikon (purple root) has been known as a Chinese medicine since ancient times. For example, an ointment "purple cloud plaster" was made from the extract of dried roots of purple plants, which caused skin diseases and trauma. It is often used as a medicine.
ところで、口腔内疾患、たとえば歯槽膿漏、口肉炎、
非痛に対する治療法として、各種の生理活性成分を含有
した軟膏や液剤などの局所投与が行われているが、この
方法では、投与後短時間で唾液等に溶解して飲み下され
てしまい、患部に薬物を長時間滞めておくことが困難
で、薬効の持続時間を長く保てないという欠点がある。By the way, oral diseases such as alveolar pyorrhea, stomatitis,
As a treatment method for non-pain, topical administration of ointments and solutions containing various physiologically active ingredients is performed, but in this method, it is dissolved in saliva etc. in a short time after administration and swallowed, It is difficult to hold the drug in the affected area for a long time, and there is a drawback that the duration of drug effect cannot be maintained for a long time.
本発明者らは、優れた抗炎症活性を持つシコンを用
い、優れた形態安定性を有し粘膜への密着性、柔軟性、
薬効持続性に優れる新規な口腔粘膜貼付剤を提供するた
め鋭意研究を進めたところ、特定成分の粘着層および非
粘着支持体層から成る製剤において、その粘着層にシコ
ンエキスを含有すれば、所期目的の口腔内貼付剤が得ら
れることを見出し、本発明を完成させるに至つた。The present inventors have used Sicon having excellent anti-inflammatory activity, have excellent morphological stability, adherence to mucous membranes, flexibility,
As a result of intensive research to provide a novel oral mucous membrane patch with excellent drug efficacy persistence, in a formulation consisting of an adhesive layer of a specific component and a non-adhesive support layer, if the adhesive layer contains Sikon extract, The inventors have found that the target oral patch can be obtained, and have completed the present invention.
発明の構成と効果 すなわち、本発明は、セルロース低級アルキルエーテ
ル類とポリアクリル酸もしくはその医薬的に許容しうる
塩およびクエン酸トリエチルからなる粘着層、および水
不溶性または水膨潤性高分子物質からなる非粘着支持体
層から成り、上記粘着層に生理活性成分としてシコンエ
キスを含有したことを特徴とするシコン含有口腔粘膜貼
付剤を提供するものである。Structure and Effect of the Invention That is, the present invention comprises an adhesive layer composed of cellulose lower alkyl ethers, polyacrylic acid or a pharmaceutically acceptable salt thereof and triethyl citrate, and a water-insoluble or water-swellable polymer substance. It is intended to provide a shicon-containing oral mucous membrane patch which comprises a non-adhesive support layer and contains shikon extract as a physiologically active ingredient in the adhesive layer.
本発明における粘着層は、口腔粘膜に付着可能なフイ
ルム状のシコン含有層であつて、患部に薬物を付与す
る。ここで用いるセルロース低級アルキルエーテル類と
しては、たとえばメチルセルロース、エチルセルロー
ス、ヒドロキシエチルセルロース、ヒドロキシプロピル
セルロース、ヒドロキシプロピルメチルセルロース、ヒ
ドロキシプロピルメチルセルロースアセテートサクシネ
ートなどが挙げられ、これらの少なくとも1種を使用に
供する(特に、エチルセルロース、ヒドロキシプロピル
メチルセルロース、ヒドロキシプロピルメチルセルロー
スアセテートサクシネートが好ましい)。またポリアク
リル酸の医薬的に許容しうる塩としては、ナトリウム
塩、カリウム塩などのアルカリ金属塩やアンモニウム塩
が挙げられる。The adhesive layer in the present invention is a film-like silicon-containing layer capable of adhering to the oral mucosa and applies a drug to the affected area. Examples of the cellulose lower alkyl ethers used here include methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxypropyl methyl cellulose acetate succinate and the like, and at least one of them is used (particularly, Ethylcellulose, hydroxypropylmethylcellulose, hydroxypropylmethylcellulose acetate succinate are preferred). Examples of the pharmaceutically acceptable salt of polyacrylic acid include alkali metal salts such as sodium salt and potassium salt, and ammonium salt.
かかる粘着層は乾燥重量中、一般に口腔粘膜に対する
付着力やフイルム強度もしくは柔軟度等を考慮して、セ
ルロース低級アルキルエーテル類5〜70%(重量%、以
下同様)(好ましくは10〜60%)とポリアクリル酸もし
くはその医薬的に許容しうる塩10〜90%(好ましくは20
〜85%)、これに5〜30%の可塑剤であるクエン酸トリ
エチルおよび0.5〜10%のシコンエキスを含有する。こ
れ以外に、通常の賦形剤、着色剤、矯味剤、矯臭剤等が
適量配合されていてもよい。Such an adhesive layer generally contains 5 to 70% (lower percent by weight) of cellulose lower alkyl ethers (preferably 10 to 60%) in dry weight, in consideration of adhesion to the oral mucosa, film strength or flexibility. And polyacrylic acid or a pharmaceutically acceptable salt thereof 10 to 90% (preferably 20%)
~ 85%), which contains 5-30% plasticizer triethyl citrate and 0.5-10% shikon extract. In addition to the above, appropriate amounts of usual excipients, coloring agents, flavoring agents, flavoring agents and the like may be added.
なお、かかる粘着層にあつて、ポリアクリル酸とたと
えばアミノアルキルメタクリレートやポリビニルアルコ
ールなどの水溶性高分子物質との組合せでは付着性(貼
付性)に劣ることが認められる(後記比較例1,2参
照)。In addition, in such an adhesive layer, it is recognized that the combination of polyacrylic acid and a water-soluble polymer substance such as aminoalkyl methacrylate or polyvinyl alcohol is inferior in adhesiveness (pasting property) (Comparative Examples 1 and 2 below). reference).
本発明における非粘着支持体層は、柔軟なフイルム状
の層であつて、柔軟性および薬効持続性を付与する。主
成分である水不溶性または水膨潤性高分子物質として
は、たとえばセルロース低級アルキルエーテル類(エチ
ルセルロース、ヒドロキシプロピルメチルセルロースア
セテートサクシネート、ヒドロキシプロピルメチルセル
ロースフタレート、カルボキシメチルセルロース、カル
ボキシメチルエチルセルロースなど)、シエラツク、ポ
リビニルアセタール、ジエチルアミノアセテート、メタ
クリル酸コポリマーが挙げられ、これらの少なくとも1
種を使用し供する(特に、エチルセルロース、ヒドロキ
シプロピルメチルセルロースアセテートサクシネートが
好ましい。)。これ以外にも、上記粘着層で例示した可
塑剤や他の配合成分を適量使用してもよい。The non-adhesive support layer in the present invention is a flexible film-like layer, and imparts flexibility and drug effect durability. Examples of the water-insoluble or water-swellable polymer substance as a main component include, for example, cellulose lower alkyl ethers (ethyl cellulose, hydroxypropylmethyl cellulose acetate succinate, hydroxypropylmethyl cellulose phthalate, carboxymethyl cellulose, carboxymethyl ethyl cellulose, etc.), sierracs, polyvinyl acetals. , Diethylaminoacetate, methacrylic acid copolymer, at least one of which
A seed is used and provided (in particular, ethylcellulose and hydroxypropylmethylcellulose acetate succinate are preferable). In addition to this, the plasticizers and other compounding ingredients exemplified in the above-mentioned adhesive layer may be used in appropriate amounts.
本発明に係る口腔粘膜貼付剤は、常法に従つて形成し
た上記シコン含有粘着層および非粘着支持体層のフイル
ムラミネート層を、適当な形状(円形、楕円形、角形)
に打抜くことにより得られる。各層の厚みは通常、粘着
層50〜150μm、および支持体層20〜50μmに選定すれ
ばよい。The oral mucosa patch according to the present invention has a film laminate layer of the above-mentioned silicon-containing adhesive layer and non-adhesive support layer formed according to a conventional method, having an appropriate shape (circular, elliptical, rectangular).
It is obtained by punching. Generally, the thickness of each layer may be selected as an adhesive layer of 50 to 150 μm and a support layer of 20 to 50 μm.
このようにして得られる本発明貼付剤は、たとえば直
径5〜15mm、総厚70〜200μmの円形片として供される
ので、口腔内への適用に非常にマツチすることができ、
その需要度は極めて高いものといえる。しかも、その薬
効などの面においても以下の利点を奏することができ
る。The patch of the present invention thus obtained is provided, for example, as a circular piece having a diameter of 5 to 15 mm and a total thickness of 70 to 200 μm, and therefore can be very suitable for application in the oral cavity.
It can be said that the demand is extremely high. Moreover, the following advantages can be achieved in terms of its medicinal effect and the like.
1.口腔粘膜に強固に長時間付着し、患部に対して適確に
直接、抗炎症作用を発揮する。1. It firmly adheres to the oral mucosa for a long time and exerts an anti-inflammatory effect directly and accurately on the affected area.
2.口腔内において特に溶解して流出せず、膨潤した形態
を比較的長時間にわたつて保つ。2. It keeps the swollen form for a relatively long time without dissolving and flowing out in the oral cavity.
3.製剤中のシコン含量の変化によつて所望の薬物濃度が
得られる他、厚みや付着面積を変えても所望の薬物量を
容易に得ることができる。3. A desired drug concentration can be obtained by changing the silicon content in the preparation, and a desired drug amount can be easily obtained even if the thickness or the adhesion area is changed.
次に実施例および比較例を挙げて、本発明をより具体
的に説明する。なお、本発明はこれらの実施例に限定さ
れるものではない。Next, the present invention will be described more specifically with reference to examples and comparative examples. The present invention is not limited to these examples.
参考例 エチルセルロース0.6g、ポリアクリル酸5gおよびグリ
セリン脂肪酸エステル0.6gをエタノール40g中で練合
し、ペースト状とした後シコンエキス0.1gを加え、再度
練合し、これを厚み70μmとなるように紙セパレーター
上に展延、乾燥してシコン含有粘着層を形成する。Reference example 0.6 g of ethyl cellulose, 5 g of polyacrylic acid and 0.6 g of glycerin fatty acid ester are kneaded in 40 g of ethanol to form a paste, 0.1 g of shikon extract is added, and kneaded again to make a paper with a thickness of 70 μm. Spread on a separator and dry to form an adhesive layer containing silicon.
さらに、この粘着層の片面にエチルセルロースとヒマ
シ油のエタノール溶液を厚み30μmとなるように均一に
塗布、乾燥して非粘着支持体層を形成して、二層構造の
フイルムラミネート層を得、次いで直径10mmの円形に打
抜いて口腔粘膜貼付剤を得る。Further, an ethanol solution of ethyl cellulose and castor oil was evenly applied to one surface of the adhesive layer so as to have a thickness of 30 μm and dried to form a non-adhesive support layer to obtain a film laminate layer having a two-layer structure. Punching into a circle with a diameter of 10 mm gives an oral mucosa patch.
実施例1 参考例において、エチルセルロース0.6g、ヒドロキシ
プロピルメチルセルロースアセテートサクシネート5g、
ポリアクリル酸2.5gおよびクエン酸トリエチル2gをエタ
ノール30g中、撹拌練合した後シコンエキス0.2gを加え
たものを用いてシコン含有粘着層を形成する以外は、同
様にフイルムラミネート層の形成、次いで打抜きを行い
口腔粘膜貼付剤を得る。Example 1 In Reference Example, 0.6 g of ethyl cellulose, 5 g of hydroxypropylmethyl cellulose acetate succinate,
2.5 g of polyacrylic acid and 2 g of triethyl citrate in 30 g of ethanol were stirred and kneaded, and then a film-laminated layer was formed in the same manner except that a shikon-containing pressure-sensitive adhesive layer was formed using a mixture containing 0.2 g of shikon extract and then punched. Then, an oral mucosa patch is obtained.
実施例2 エチルセルロース0.6gおよびクエン酸トリエチル2gを
エタノール70gに溶解し、ヒドロキシプロピルメチルセ
ルロース2.5g、ポリアクリル酸5gおよび水10gを加え、
練合してペースト状とした後、シコンエキス0.15gを加
え、再度練合し、これを厚み70μmとなるように均一に
塗布、乾燥してシコン含有粘着層を形成する。Example 2 0.6 g of ethyl cellulose and 2 g of triethyl citrate were dissolved in 70 g of ethanol, 2.5 g of hydroxypropylmethyl cellulose, 5 g of polyacrylic acid and 10 g of water were added,
After kneading to form a paste, 0.15 g of shikon extract is added and kneaded again, and this is uniformly applied to a thickness of 70 μm and dried to form a shikon-containing adhesive layer.
さらに、この粘着層の片面にエチルセルロース、ヒド
ロキシプロピルメチルセルロースアセテートサクシネー
トおよびグリセリン脂肪酸エステルのエタノール溶液を
厚み30μmとなるように展延、乾燥して非粘着支持体層
を形成して、二層構造のフイルムラミネート層を得、次
いで直径10mmの円形に打抜いて口腔粘膜貼付剤を得る。Further, an ethanol solution of ethyl cellulose, hydroxypropylmethyl cellulose acetate succinate and glycerin fatty acid ester was spread on one surface of the adhesive layer to a thickness of 30 μm and dried to form a non-adhesive support layer, and a two-layer structure was formed. A film laminate layer is obtained and then punched into a circle having a diameter of 10 mm to obtain an oral mucosa patch.
比較例1 アミノアルキルメタアクリレートコポリマー3g、ポリ
アクリル酸4gおよびポリエチレングリコール3gをエタノ
ール20g中に分散し、水50gを加え、ペースト状とした後
シコンエキス0.2gを加え、以下参考例と同様にしてシコ
ン含有粘着層を形成させ、ついでフイルムラミネート層
の形成、次いで打抜きを行い口腔粘膜貼付剤を得る。Comparative Example 1 3 g of an aminoalkyl methacrylate copolymer, 4 g of polyacrylic acid and 3 g of polyethylene glycol were dispersed in 20 g of ethanol, 50 g of water was added to form a paste, and 0.2 g of shikon extract was added, followed by the same procedure as in the following reference example. A containing adhesive layer is formed, then a film laminate layer is formed, and then punching is performed to obtain an oral mucosa patch.
比較例2 ポリアクリル酸5g、ポリエチレングリコール3gをエタ
ノール15g中で混合し、ポリビニルアルコール6gの水溶
液50gおよびシコンエキス0.25gを加え、これを用いて実
施例1と同様にしてシコン含有粘着層を形成させ、さら
に、打抜き形状を長径18mm、短径6mmの楕円形とする以
外は、同様にフイルムラミネート層の形成、次いで打抜
きを行い口腔粘膜貼付剤を得る。Comparative Example 2 5 g of polyacrylic acid and 3 g of polyethylene glycol were mixed in 15 g of ethanol, 50 g of an aqueous solution of 6 g of polyvinyl alcohol and 0.25 g of shikon extract were added, and a sticky layer containing shikon was formed in the same manner as in Example 1. Further, an oral mucosal patch is obtained by forming a film laminate layer and then punching in the same manner except that the punched shape is an elliptical shape having a major axis of 18 mm and a minor axis of 6 mm.
これらの貼付剤について、その特徴的な性質をモデル
的に示すため下記の実験を行つた。The following experiments were conducted for these patches to show their characteristic properties as a model.
実験1(付着試験) 0.1M−リン酸塩緩衝溶液(pH7.4)を入れたビーカー
内の側面に、各貼付剤をそれぞれ8枚づつ貼付し、マグ
ネチツクスターラーで200rpmにて撹拌しながら5時間後
まで、その脱落状況を観察した。結果を表1に示す。Experiment 1 (Adhesion test) 8 patches of each patch were applied to the sides of the beaker containing 0.1M-phosphate buffer solution (pH 7.4), and the mixture was stirred with a magnetic stirrer at 200 rpm. Until the time passed, the dropout condition was observed. Table 1 shows the results.
実験2(貼付試験) 各貼付剤をボランテイア10名のそれぞれの歯肉粘膜に
貼付し、自然に剥離するまでの時間を調べた。結果を表
2に示す。 Experiment 2 (Patch test) Each patch was stuck to the gingival mucosa of 10 volunteers, and the time until spontaneous peeling was examined. Table 2 shows the results.
実験3(血管透過性亢進抑制試験) 実験動物としてハムスターを用い、軽麻酔下に1%Ev
an′s blueを静脈内に投与(0.5m/100Bu)し、直ちに右
側頬袋を反転露出せしめ、直径10mmのキシレン含浸フエ
ルトで頬袋粘膜を30秒間刺激した後、被試験試料を適用
する(適用時間は1時間および2時間とする)。所定時
間経過後、右側頬袋を皮膚と共に切取り、青染部の長径
と短径を測定し、その積(mm2)を指数として用いた。
結果を表3に示す。 Experiment 3 (Vascular hyperpermeability inhibition test) 1% Ev under light anesthesia using a hamster as an experimental animal
An's blue is administered intravenously (0.5m / 100Bu), the right cheek pouch is immediately exposed by inversion, and the cheek pouch mucosa is stimulated with xylene-impregnated felt with a diameter of 10 mm for 30 seconds, and then the test sample is applied (application time Is 1 hour and 2 hours). After the lapse of a predetermined time, the right cheek pouch was cut out together with the skin, the major axis and the minor axis of the blue dyed portion were measured, and the product (mm 2 ) was used as an index.
Table 3 shows the results.
フロントページの続き (72)発明者 関 美地子 香川県大川郡大内町三本松1041―5 (56)参考文献 特開 昭56−22720(JP,A) 特開 昭56−18912(JP,A) 特開 昭57−58613(JP,A) 実願 昭59−30662号(実開 昭60− 143737号)の願書に添付した明細書及び 図面の内容を撮影したマイクロフィルム (JP,U)Front Page Continuation (72) Inventor Sachi Michiko 1041-5 Sanbonmatsu, Ouchi-machi, Okawa-gun, Kagawa (56) References JP-A-56-22720 (JP, A) JP-A-56-18912 (JP, A) Special Kai 57-58613 (JP, A) Actual application 59-30662 (Act 60-143737) The microfilm (JP, U) taken from the specification and drawings attached to the application.
Claims (3)
アクリル酸もしくはその医薬的に許容しうる塩およびク
エン酸トリエチルからなる粘着層、および水不溶性また
は水膨潤性高分子からなる非粘着支持体層から成り、上
記粘着層に生理活性成分としてシコンエキスを含有する
ことを特徴とするシコン含有口腔粘膜貼付剤。1. An adhesive layer comprising cellulose lower alkyl ethers, polyacrylic acid or a pharmaceutically acceptable salt thereof and triethyl citrate, and a non-adhesive support layer comprising a water-insoluble or water-swellable polymer. A shikon-containing oral mucosal patch, wherein the adhesive layer contains a shikon extract as a physiologically active ingredient.
チルセルロース、ヒドロキシプロピルメチルセルロース
およびヒドロキシプロピルメチルセルロースアセテート
サクシネートの少なくとも1種である請求項第1項記載
の貼付剤。2. The patch according to claim 1, wherein the cellulose lower alkyl ether is at least one kind of ethyl cellulose, hydroxypropylmethyl cellulose and hydroxypropylmethyl cellulose acetate succinate.
チルセルロースおよび/またはヒドロキシプロピルメチ
ルセルロースアセテートサクシネートである請求項第1
項または第2項記載の貼付剤。3. The water-insoluble or water-swellable polymer substance is ethyl cellulose and / or hydroxypropylmethyl cellulose acetate succinate.
Item or the patch according to Item 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63057052A JP2685055B2 (en) | 1988-03-08 | 1988-03-08 | Oral mucosa patch containing Sikon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63057052A JP2685055B2 (en) | 1988-03-08 | 1988-03-08 | Oral mucosa patch containing Sikon |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01226823A JPH01226823A (en) | 1989-09-11 |
JP2685055B2 true JP2685055B2 (en) | 1997-12-03 |
Family
ID=13044675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63057052A Expired - Lifetime JP2685055B2 (en) | 1988-03-08 | 1988-03-08 | Oral mucosa patch containing Sikon |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2685055B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800832A (en) | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
CA2329128C (en) * | 1998-04-29 | 2008-03-18 | Virotex Corporation | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
PL2054031T3 (en) | 2006-07-21 | 2016-09-30 | Transmucosal delivery devices with enhanced uptake | |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
JP7143996B2 (en) * | 2018-01-19 | 2022-09-29 | 東洋化学株式会社 | Oral mucosal protective film |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5618912A (en) * | 1979-07-25 | 1981-02-23 | Lion Corp | Oral band |
JPS5835965B2 (en) * | 1979-07-31 | 1983-08-05 | ライオン株式会社 | Oral composition |
JPS5758613A (en) * | 1980-09-26 | 1982-04-08 | Lion Corp | Composition for oral cavity application |
JPS60143737U (en) * | 1984-03-05 | 1985-09-24 | 小川 裕三 | oral patch |
-
1988
- 1988-03-08 JP JP63057052A patent/JP2685055B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH01226823A (en) | 1989-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4876092A (en) | Sheet-shaped adhesive preparation applicable to oral cavity | |
US4594240A (en) | Sheet-shape adhesive preparation | |
DE69736641T2 (en) | Pharmaceutical carrier composition for use on mucosal surfaces | |
JPH02202815A (en) | Plaster for mucosa of oral cavity and plaster preparation for mucosa of oral cavity | |
JPH02202814A (en) | Plaster preparation for mucosa of oral cavity | |
JPS6185315A (en) | Sheet-like preparation | |
GB2177002A (en) | Adhesive medical tapes | |
TWI343263B (en) | Patches for mucosa of oral cavity containing fentanyl | |
US20180311147A1 (en) | Self-adhesive film for teeth | |
US20070298087A1 (en) | Two-phase mucoadhesive composition | |
JPS62135417A (en) | Filmy pharmaceutical | |
JP2685055B2 (en) | Oral mucosa patch containing Sikon | |
CN113713113B (en) | Composition for treating oral mucosa diseases and preparation method thereof | |
JP2694964B2 (en) | Gingival application type local anesthesia patch | |
JP2635336B2 (en) | Sustained release oral preparation | |
JPH044296B2 (en) | ||
KR0170574B1 (en) | Oral mucoadhesive patch | |
JP2716196B2 (en) | Oral bandage | |
JPS59186913A (en) | Base to be applied to mucosa in oral cavity | |
KR100299231B1 (en) | Oral mucosa adhesive pharmaceutical preparation containing triamcinolone acetonide | |
JPS60214732A (en) | Application agent for external use | |
JPS6222713A (en) | Mucosa adherent preparation | |
CN115501198B (en) | Gum paste for relieving pain and diminishing inflammation and preparation method thereof | |
JP2801238B2 (en) | Oral base material | |
AU635937B2 (en) | A preparation for the treatment of fungal infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080815 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080815 Year of fee payment: 11 |